Literature DB >> 8188347

Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

P J Baker1, T Hraba, C E Taylor, P W Stashak, M B Fauntleroy, U Zähringer, K Takayama, T R Sievert, X Hronowski, R J Cotter.   

Abstract

The relationship between chain length as well as the position of fatty acyl groups to the ability of lipid A to abolish the expression of suppressor T-cell (Ts) activity was examined. Fatty acyl chain lengths of C12 to C14, as in the lipid A of Escherichia coli and Salmonella minnesota, appear to be optimal for this bioactivity, since lipid A preparations with fatty acyl groups of relatively short chain length (C10 to C12 for Pseudomonas aeruginosa and Chromobacterium violaceum) or predominantly long chain length (C18 for Helicobacter pylori) are without effect. The presence of an acyloxyacyl group of appropriate chain length at the 3' position of the glucosamine disaccharide backbone of lipid A also plays a decisive role. By contrast, the lipid A proximal inner core region oligosaccharides of some bacterial lipopolysaccharides increase the expression of Ts activity; this is due mainly to the capacity of such oligosaccharides, which are relatively conserved in structure among gram-negative bacteria, to enlarge or expand upon the population of CD8+ Ts generated during the course of a normal antibody response to unrelated microbial antigens. The minimal structure required for the expression of the added immunosuppression observed appears to be a hexasaccharide containing one 2-keto-3-deoxyoctonate residue, two glucose residues, and three heptose residues to which are attached two pyrophosphorylethanolamine groups. The relevance of these findings to virulence and to the pathogenesis of gram-negative infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188347      PMCID: PMC186506          DOI: 10.1128/iai.62.6.2257-2269.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.

Authors:  J M Jones; D F Amsbaugh; P W Stashak; B Prescott; P J Baker; D W Alling
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM.

Authors:  M J OSBORN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-09       Impact factor: 11.205

3.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

4.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

5.  Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.

Authors:  P H Baker; P W Stashak
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

6.  Cell-wall lipopolysaccharide from Escherichia coli B.

Authors:  P Prehm; S Stirm; B Jann; K Jann
Journal:  Eur J Biochem       Date:  1975-08-01

7.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

8.  A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria.

Authors:  Y D Karkhanis; J Y Zeltner; J J Jackson; D J Carlo
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

9.  Characterization of lipopolysaccharides from Escherichia coli K-12 mutants.

Authors:  H G Boman; D A Monner
Journal:  J Bacteriol       Date:  1975-02       Impact factor: 3.490

10.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03
View more
  8 in total

Review 1.  Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors:  C E Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution.

Authors:  H Zarrouk; D Karibian; S Bodie; M B Perry; J C Richards; M Caroff
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

Review 3.  Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.

Authors:  Magdalena Chmiela; Eliza Miszczyk; Karolina Rudnicka
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Escherichia coli msbB gene as a virulence factor and a therapeutic target.

Authors:  J E Somerville; L Cassiano; R P Darveau
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 5.  Metabolism and genetics of Helicobacter pylori: the genome era.

Authors:  A Marais; G L Mendz; S L Hazell; F Mégraud
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

6.  Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides.

Authors:  A P Moran; B Lindner; E J Walsh
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 7.  Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.

Authors:  Rita F Maldonado; Isabel Sá-Correia; Miguel A Valvano
Journal:  FEMS Microbiol Rev       Date:  2016-04-12       Impact factor: 16.408

8.  Molecular structure of endotoxins from Gram-negative marine bacteria: an update.

Authors:  Serena Leone; Alba Silipo; Evgeny L Nazarenko; Rosa Lanzetta; Michelangelo Parrilli; Antonio Molinaro
Journal:  Mar Drugs       Date:  2007-09-19       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.